Zimbuck – Your Market. Your Community.

October 30's Sell-Off Hid a Rotation: Tech Crashed 2.86% While Biotech Rose 4.3% for the Week

5 Min. Lesezeit
0
Kommentare
64
Aufrufe

### A brutal Friday, an uneven week

Friday, October 30, 2026 was the worst day for American tech stocks since June. The Nasdaq Composite fell 2.86% to 25,437, the S&P 500 lost 1.82% to 7,580, and the Dow Jones Industrial Average dropped 572 points, or 1.09%, to 51,770. The trigger was earnings: Intel plunged 28.6% after a weak outlook overshadowed better-than-expected third-quarter results, AMD fell 10.9%, and Alphabet, Amazon and Meta had all reported results in the same week that raised questions about the cost of the artificial-intelligence buildout rather than confidence in its returns — Alphabet suffered the largest one-day loss of market value in its history the day before, and Meta reported negative quarterly free cash flow for the first time in more than a decade. But the headline hides the more interesting story. For the week as a whole, the S&P 500 finished down only 0.6%, and its equal-weight version — which treats every company the same instead of letting giants dominate — actually closed the week up 0.8%. Money did not leave the market on Friday. It moved.

### Where the money went

The clearest winners of the week were the sectors the AI trade had left behind. The biotech ETF XBI gained 4.3% for the week, homebuilders picked up 2.6%, while software stocks fell 5.9% and communication services dropped 5.2%. Gilead gapped up and finished Friday up 4.26% to $172.67 after beating earnings expectations — $2.55 per share against a $2.19 consensus, on revenue of $8.30 billion that topped estimates by about $500 million. Incyte added 4.14% on its own report, with total revenue of $1.56 billion, up 14% year over year, and a raised forecast for its Opzelura franchise. The rotation has a logic: after months in which a handful of AI giants drove most of the market's gains, investors are paying for earnings that already exist — drugs selling today, houses being built today — rather than for spending promises about tomorrow. The fear gauge, the VIX, still rose 12.9% on Friday to 19.42, and the 10-year Treasury yield eased to about 4.93%, so nobody is calling this calm. But a sell-off where defensive and value sectors rise is a different animal from a panic where everything falls together.

### October's split verdict

The month closed with three indexes telling three different stories. The Nasdaq lost 5.3% in October, its worst month since March 2025, and finished 7.8% below the record of 27,599.79 it set on October 6. The S&P 500 slipped 0.9% for the month. The Dow rose 1.7%. Less than four weeks earlier, the Nasdaq and the S&P 500 were closing at record highs; what changed in between was a single crowded week of earnings from the companies that dominate both indexes, graded on cash rather than growth. Reddit's 29.2% fall to $91.73, its worst day since its 2024 listing, after guiding fourth-quarter revenue below forecasts, underlined the new grading curve: growth stories that cannot show the cash are being marked down first. The strategists are split on what follows — Goldman Sachs holds an 8,000 year-end S&P 500 target with 8,700 over twelve months, while Bank of America is more cautious at 7,400 — but both camps agree the next test comes fast: Apple reports on Monday, the midterm elections land on Tuesday, and the October jobs report arrives on Friday.

### What this rotation means for ordinary investors

First, do not read a tech-led sell-off as a whole-market verdict; check breadth, the equal-weight index and the sectors, before concluding everything is falling. Second, earnings season now punishes spending without a payoff timeline — the question for every AI-heavy report is not how much a company spent, but when that spending turns into cash. Third, rotations are where discipline pays: the investors who owned some biotech, healthcare or homebuilders before Friday did not need to predict Intel's outlook to cushion the fall. None of this is a call to buy the dip or to sell everything — October's split month argues for balance, not for heroics, and the midterm week ahead can easily reverse a rotation as fast as it created one. The useful habit is the same one every earnings season rewards: judge each company on its own numbers, watch where money actually moves rather than where headlines point, and let the rotation, not the panic, tell you what the market is really repricing.

### FAQ

**How far did stocks fall on October 30, 2026?** The Nasdaq fell 2.86% to 25,437, its worst day since June; the S&P 500 lost 1.82% to 7,580; the Dow fell 1.09% to 51,770.

**Why did tech fall?** Earnings from Alphabet, Amazon, Intel and Meta raised questions about AI spending costs, with Intel plunging 28.6% on a weak outlook and AMD falling 10.9%.

**What rose instead?** Biotech (XBI +4.3% for the week) and homebuilders (+2.6%), led by Gilead (+4.26% Friday on an earnings beat) and Incyte (+4.14%).

**How did October end overall?** Nasdaq −5.3% (worst since March 2025), S&P 500 −0.9%, Dow +1.7% — a split month, not a uniform crash.

**What comes next?** Apple earnings on Monday, the US midterm elections on Tuesday, and the October jobs report on Friday.

Read more on Zimbuck: https://zimbuck.com/pages/zimbucknews and join the discussion at https://zimbuck.com/groups/zimbuckmarketnews . Related reading on the site: the October market coverage in the Stock Market category.

This article is market news and general information only, not financial advice.